피부은행 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측(2021-2031년)

The Global Skin Bank Market is projected to expand from USD 2.43 Billion in 2025 to USD 3.69 Billion by 2031, registering a CAGR of 7.21%. Skin banks function as specialized medical facilities focused on the harvesting, processing, preservation, and distribution of human skin allografts, which are crucial biological dressings for managing severe burns and significant tissue loss. This growth is primarily driven by the increasing frequency of burn injuries alongside advancements in graft preservation technologies that prolong tissue viability. Data from the American Burn Association highlights this urgent need, reporting 32,993 acute burn admissions across 114 centers in 2024, emphasizing the continuous demand for viable donor tissue to treat complex trauma cases.

Despite these drivers, the market faces significant hurdles due to a chronic shortage of skin donations, a problem largely attributed to limited public awareness and cultural or religious reservations concerning post-mortem donation. This scarcity results in a considerable gap between supply and demand, compelling healthcare providers to depend on alternative treatments and restricting the broad availability of biological skin banking services. Consequently, the difficulty in maintaining sufficient allograft inventories persists as a major barrier to the further expansion and development of this sector.

Market Driver

The growing incidence of burn injuries and severe trauma serves as a major driver for the global skin bank market, creating an urgent need for a steady supply of allografts for acute wound management. Because severe burns frequently damage extensive skin surface areas, immediate biological dressings are essential to halt infection, minimize fluid loss, and expedite healing prior to permanent autografting. This sustained demand is underscored by recent injury statistics; for example, the Children's Burns Trust announced in October 2025, as part of 'National Burn Awareness Day 2025', that data from the International Burn Injury Database indicated a 16.4% increase in children admitted to specialist burns services for severe hot drink burns between 2022 and 2024. Such increases in trauma cases directly heighten the pressure on skin banks to secure sufficient tissue stocks.

In parallel, the rising prevalence of skin cancer and melanoma is substantially fueling market growth, as surgical treatments often require extensive tissue removal necessitating grafts for reconstruction. As malignancy rates increase, the demand for post-excision reconstructive options drives the use of banked skin and advanced substitutes. According to the 'Cancer Facts & Figures 2025' report released by the American Cancer Society in January 2025, approximately 104,960 new melanoma cases were projected in the United States for the year, highlighting the expanding patient population requiring dermatological surgery. This surge in clinical need is mirrored in the financial results of major sector participants; Vericel Corporation reported in February 2025 that its burn care net revenue grew by 22% to $39.9 million for the full year 2024, indicating strong commercial momentum within the skin repair industry.

Market Challenge

A critical bottleneck restricting the growth of the Global Skin Bank Market is the persistent shortage of skin donations. This scarcity generates a continuous gap between supply and demand, as skin banks often struggle to keep adequate inventories of the allografts needed for treating widespread trauma. When the supply of biological skin falls short of the immediate clinical requirements of burn units, medical providers are forced to rely on synthetic substitutes or xenografts. Such dependence on alternative therapies constrains the broader adoption of human skin banking services and negatively impacts the revenue potential for facilities engaged in allograft processing and storage.

The consequences of this shortage are further amplified by the high volume of trauma cases necessitating intervention. For instance, the Children's Burns Trust reported that 9,244 children suffered burns or scalds in 2024. This significant number, representing just one demographic segment, underscores the immense strain placed on available tissue supplies. Since the rate of donation fails to align with the high frequency of these injuries, the market faces difficulties in scaling operations efficiently. The inability to ensure a reliable supply of viable tissue ultimately weakens confidence in bio-banking systems and impedes the overall advancement of the sector.

Market Trends

The market is being fundamentally reshaped by a transition toward hybrid and bio-engineered skin products as providers look for alternatives to traditional cadaveric allografts to overcome supply inconsistencies. This shift is powered by advanced cellular and synthetic matrices that deliver improved wound closure rates and lower rejection risks, effectively countering the limitations of donor availability. These bio-engineered solutions are securing commercial traction by offering off-the-shelf convenience for the treatment of chronic wounds and burns, which reduces dependence on unpredictable biological inventories. This commercial progress is evident in the performance of major industry players; Integra LifeSciences reported total revenues of $1.61 billion in its 'Fourth Quarter and Full-Year 2024 Financial Results' in February 2025, highlighting the strong demand for its regenerative tissue portfolio despite operational hurdles.

Concurrently, the uptake of minimally invasive micro-grafting technologies is revolutionizing burn care by significantly decreasing the amount of donor skin needed to treat extensive injuries. These systems employ autologous cell harvesting to generate grafts that cover wound areas much larger than the donor site, thereby reducing patient trauma and hastening epithelialization. This technology directly tackles the critical challenge of limited donor skin availability and is quickly emerging as a standard of care for thermal burn management. Underscoring this trend, Avita Medical announced in February 2025, within its 'Fourth Quarter and Full Year 2024 Financial Results', that it achieved commercial revenue of $64.0 million, a 29% increase attributed to the growing use of its RECELL system in trauma centers.

Key Market Players

• National Burns Centre
• Yorkshire Regional Tissue Bank
• Dutch National Skin Bank
• Euro Skin Bank
• Evangelical University Hospital of Curitiba (HUEC) Skin Bank
• Ganga Hospital Skin Bank
• Singapore General Hospital (SGH) Skin Bank
• New York Firefighters Skin Bank
• Helsinki Skin Bank
• OGH Skin Bank

Report Scope

In this report, the Global Skin Bank Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Skin Bank Market, By Skin Graft

• Autograft v/s Allograft

Skin Bank Market, By Application

• Burns patient
• Orthopedic Trauma patients
• Non-Healing Ulcers
• Pressure-Source
• Others

Skin Bank Market, By Ownership

• Public
• Private
• Others

Skin Bank Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Skin Bank Market.

Available Customizations:

Global Skin Bank Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Skin Bank Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Skin Graft (Autograft v/s Allograft)
  • 5.2.2. By Application (Burns patient, Orthopedic Trauma patients, Non-Healing Ulcers, Pressure-Source, Others)
  • 5.2.3. By Ownership (Public, Private, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Skin Bank Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Skin Graft
  • 6.2.2. By Application
  • 6.2.3. By Ownership
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Skin Bank Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Skin Graft
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By Ownership
  • 6.3.2. Canada Skin Bank Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Skin Graft
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By Ownership
  • 6.3.3. Mexico Skin Bank Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Skin Graft
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By Ownership

7. Europe Skin Bank Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Skin Graft
  • 7.2.2. By Application
  • 7.2.3. By Ownership
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Skin Bank Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Skin Graft
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By Ownership
  • 7.3.2. France Skin Bank Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Skin Graft
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By Ownership
  • 7.3.3. United Kingdom Skin Bank Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Skin Graft
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By Ownership
  • 7.3.4. Italy Skin Bank Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Skin Graft
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By Ownership
  • 7.3.5. Spain Skin Bank Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Skin Graft
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By Ownership

8. Asia Pacific Skin Bank Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Skin Graft
  • 8.2.2. By Application
  • 8.2.3. By Ownership
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Skin Bank Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Skin Graft
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By Ownership
  • 8.3.2. India Skin Bank Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Skin Graft
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By Ownership
  • 8.3.3. Japan Skin Bank Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Skin Graft
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By Ownership
  • 8.3.4. South Korea Skin Bank Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Skin Graft
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By Ownership
  • 8.3.5. Australia Skin Bank Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Skin Graft
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By Ownership

9. Middle East & Africa Skin Bank Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Skin Graft
  • 9.2.2. By Application
  • 9.2.3. By Ownership
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Skin Bank Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Skin Graft
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By Ownership
  • 9.3.2. UAE Skin Bank Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Skin Graft
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By Ownership
  • 9.3.3. South Africa Skin Bank Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Skin Graft
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By Ownership

10. South America Skin Bank Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Skin Graft
  • 10.2.2. By Application
  • 10.2.3. By Ownership
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Skin Bank Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Skin Graft
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By Ownership
  • 10.3.2. Colombia Skin Bank Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Skin Graft
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By Ownership
  • 10.3.3. Argentina Skin Bank Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Skin Graft
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By Ownership

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Skin Bank Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. National Burns Centre
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Yorkshire Regional Tissue Bank
• 15.3. Dutch National Skin Bank
• 15.4. Euro Skin Bank
• 15.5. Evangelical University Hospital of Curitiba (HUEC) Skin Bank
• 15.6. Ganga Hospital Skin Bank
• 15.7. Singapore General Hospital (SGH) Skin Bank
• 15.8. New York Firefighters Skin Bank
• 15.9. Helsinki Skin Bank
• 15.10. OGH Skin Bank

16. Strategic Recommendations

17. About Us & Disclaimer